Guest guest Posted October 11, 2002 Report Share Posted October 11, 2002 Targeted Genetics: A report on October 4, 2002 at the 16th Annual North American Cystic Fibrosis Conference in New Orleans is indeed an exciting step in the Cystic Fibrosis Foundation's effort to develop gene therapies to treat cystic fibrosis (CF) at the most fundamental genetic level. Encouraging research sponsored by Targeted Genetics and conducted in the CF Foundation's Therapeutics Development Network, show that the adeno-associated virus can be safely administered in repeated doses to improve the lung function of CF patients. This is the first report of possible clinical improvements by the use of CF gene therapy. Recognizing that this study was conducted in a small number of patients, Targeted Genetics, working with Cystic Fibrosis Foundation Therapeutics, is planning new studies to validate these important findings. This study was made possible by the ongoing commitment of Targeted Genetics to bringing this technology forward, and by the willingness of individuals with CF to participate in these clinical trials. We hope to have more to report to you in the months ahead. For more information, read the official news release from Targeted Genetics. http://www.cff.org/research/cf_research_in_the_news.cfm?ID=318 ________________________________________________________________ Inspire Pharmaceuticals Early Phase II studies of INS37217 demonstrated some promising trends in improving lung function in CF patients. As a result, Cystic Fibrosis Foundation Therapeutics (CFFT) -- the nonprofit drug development affiliate of the Cystic Fibrosis Foundation -- has entered into an important alliance with Inspire Pharmaceuticals to further study this compound to validate its effects in treating cystic fibrosis. A clinical trial is being planned and will be conducted in the CFFT's Therapeutics Development Network. This significant collaborative arrangement will provide a platform to develop therapeutics to attack CF at its most fundamental molecular level. Read the official news release from Inspire Pharmaceuticals. http://www.cff.org/research/cf_research_in_the_news.cfm?ID=320 Becki YOUR FAVORITE LilGooberGirl YOUNGLUNG EMAIL SUPPORT LIST www.topica.com/lists/younglung Pediatric Interstitial Lung Disease Society http://groups.yahoo.com/group/InterstitialLung_Kids/ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.